Legend Biotech Corp (LEGN)
32.80
-1.13
(-3.33%)
USD |
NASDAQ |
Dec 24, 16:00
Legend Biotech Shareholders Equity (Quarterly): 1.116B for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Johnson & Johnson | 70.16B |
| Gilead Sciences Inc | 18.47B |
| Ligand Pharmaceuticals Inc | 841.18M |
| Arcellx Inc | 483.02M |
| CEL-SCI Corp | 8.473M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.736B |
| Total Liabilities (Quarterly) | 619.72M |
| Debt to Equity Ratio | 0.2658 |
| Current Ratio | 4.984 |
| Net Debt Paydown Yield | -0.06% |